Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-15

Clinical Trial Update: Biomarker 11-dh-TXB2 in Blood and Urine Samples From Patients With Prostate Cancer and Healthy Volunteers

View source ↗

Summary

This clinical trial update reports measurements of the biomarker 11-dh-TXB2 in blood and urine from prostate cancer patients and healthy volunteers. The study s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Prostate Cancer | Status: COMPLETED